Class II · Moderate risk
Glycopyrrolate Injection
CGMP Deviations: recalling drug products following an FDA inspection.
National Drug Code
Is NDC 16729-0472-30 recalled?
Glycopyrrolate
Yes — this exact package was recalled
2 FDA recalls name the code 16729-0472-30 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- glycopyrrolate
- Strength
- GLYCOPYRROLATE .2 mg/mL
- Form
- Injection · Intramuscular, Intravenous
- Labeler
- Accord Healthcare, Inc.,
- Type
- Human Prescription Drug
- Product code
- 16729-0472
Recalls naming this package
Class III · Low risk
Glycopyrrolate Injection
Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 16729-0447 Levothyroxine sodium 4
- 16729-0448 Levothyroxine sodium 3
- 16729-0450 Levothyroxine sodium 3
- 16729-0452 Levothyroxine sodium 3
- 16729-0182 Hydrochlorothiazide 2
- 16729-0434 Daptomycin 2
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.